Advertisement

Index by author

July 01, 2006; Volume 34,Issue 7

A

  1. Adachi, Yasuhisa

    1. INVOLVEMENT OF TRANSPORTERS IN THE HEPATIC UPTAKE AND BILIARY EXCRETION OF VALSARTAN, A SELECTIVE ANTAGONIST OF THE ANGIOTENSIN II AT1-RECEPTOR, IN HUMANS
      Wakaba Yamashiro, Kazuya Maeda, Masakazu Hirouchi, Yasuhisa Adachi, Zhuohan Hu and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1247-1254; DOI: https://doi.org/10.1124/dmd.105.008938

  2. Ahlström, Håkan

    1. THE IN VIVO AND IN VITRO METABOLIC PROFILE OF 99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE
      David Edwards, Mark Battle, Rochelle Lear, Gill Farrar, D. Jon Barnett, Vanessa Godden, Catherine Coombes, Alexandra Oliveira and Håkan Ahlström
      Drug Metabolism and Disposition July 2006, 34 (7) 1128-1135; DOI: https://doi.org/10.1124/dmd.106.009696

B

  1. Barnett, D. Jon

    1. THE IN VIVO AND IN VITRO METABOLIC PROFILE OF 99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE
      David Edwards, Mark Battle, Rochelle Lear, Gill Farrar, D. Jon Barnett, Vanessa Godden, Catherine Coombes, Alexandra Oliveira and Håkan Ahlström
      Drug Metabolism and Disposition July 2006, 34 (7) 1128-1135; DOI: https://doi.org/10.1124/dmd.106.009696

  2. Battle, Mark

    1. THE IN VIVO AND IN VITRO METABOLIC PROFILE OF 99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE
      David Edwards, Mark Battle, Rochelle Lear, Gill Farrar, D. Jon Barnett, Vanessa Godden, Catherine Coombes, Alexandra Oliveira and Håkan Ahlström
      Drug Metabolism and Disposition July 2006, 34 (7) 1128-1135; DOI: https://doi.org/10.1124/dmd.106.009696

  3. Benet, Leslie Z.

    1. QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN
      Yong Huang, Hideaki Okochi, Barnaby C. H. May, Giuseppe Legname, Stanley B. Prusiner, Leslie Z. Benet, B. Joseph Guglielmo and Emil T. Lin
      Drug Metabolism and Disposition July 2006, 34 (7) 1136-1144; DOI: https://doi.org/10.1124/dmd.105.008664
    2. PHARMACOKINETICS OF ATORVASTATIN AND ITS HYDROXY METABOLITES IN RATS AND THE EFFECTS OF CONCOMITANT RIFAMPICIN SINGLE DOSES: RELEVANCE OF FIRST-PASS EFFECT FROM HEPATIC UPTAKE TRANSPORTERS, AND INTESTINAL AND HEPATIC METABOLISM
      Yvonne Y. Lau, Hideaki Okochi, Yong Huang and Leslie Z. Benet
      Drug Metabolism and Disposition July 2006, 34 (7) 1175-1181; DOI: https://doi.org/10.1124/dmd.105.009076

  4. Bergman, Ebba

    1. FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL
      Niclas Petri, Ebba Bergman, Patrik Forsell, Mikael Hedeland, Ulf Bondesson, Lars Knutson and Hans Lennernäs
      Drug Metabolism and Disposition July 2006, 34 (7) 1182-1189; DOI: https://doi.org/10.1124/dmd.105.008409

  5. Bonala, Radha R.

    1. QUANTITATIVE DETERMINATION OF ARISTOLOCHIC ACID-DERIVED DNA ADDUCTS IN RATS USING 32P-POSTLABELING/POLYACRYLAMIDE GEL ELECTROPHORESIS ANALYSIS
      Huan Dong, Naomi Suzuki, Maria C. Torres, Radha R. Bonala, Francis Johnson, Arthur P. Grollman and Shinya Shibutani
      Drug Metabolism and Disposition July 2006, 34 (7) 1122-1127; DOI: https://doi.org/10.1124/dmd.105.008706

  6. Bondesson, Ulf

    1. FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL
      Niclas Petri, Ebba Bergman, Patrik Forsell, Mikael Hedeland, Ulf Bondesson, Lars Knutson and Hans Lennernäs
      Drug Metabolism and Disposition July 2006, 34 (7) 1182-1189; DOI: https://doi.org/10.1124/dmd.105.008409

  7. Braeuning, Albert

    1. REGULATION OF CYP1A1 GENE EXPRESSION BY THE ANTIOXIDANT TERT-BUTYLHYDROQUINONE
      Thomas D. Schreiber, Christoph Köhle, Felicitas Buckler, Stefan Schmohl, Albert Braeuning, Alexander Schmiechen, Michael Schwarz and Peter A. Münzel
      Drug Metabolism and Disposition July 2006, 34 (7) 1096-1101; DOI: https://doi.org/10.1124/dmd.106.009662

  8. Buckler, Felicitas

    1. REGULATION OF CYP1A1 GENE EXPRESSION BY THE ANTIOXIDANT TERT-BUTYLHYDROQUINONE
      Thomas D. Schreiber, Christoph Köhle, Felicitas Buckler, Stefan Schmohl, Albert Braeuning, Alexander Schmiechen, Michael Schwarz and Peter A. Münzel
      Drug Metabolism and Disposition July 2006, 34 (7) 1096-1101; DOI: https://doi.org/10.1124/dmd.106.009662

C

  1. Caguyong, Michelle

    1. PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS
      Kevin J. Coe, Sidney D. Nelson, Roger G. Ulrich, Yudong He, Xudong Dai, Olivia Cheng, Michelle Caguyong, Chris J. Roberts and J. Greg Slatter
      Drug Metabolism and Disposition July 2006, 34 (7) 1266-1275; DOI: https://doi.org/10.1124/dmd.105.009159

  2. Caron, Patrick

    1. THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER
      Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
      Drug Metabolism and Disposition July 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787

  3. Chadwick, Lucas R.

    1. IDENTIFICATION OF HUMAN HEPATIC CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 8-PRENYLNARINGENIN AND ISOXANTHOHUMOL FROM HOPS (HUMULUS LUPULUS L.)
      Jian Guo, Dejan Nikolic, Lucas R. Chadwick, Guido F. Pauli and Richard B. van Breemen
      Drug Metabolism and Disposition July 2006, 34 (7) 1152-1159; DOI: https://doi.org/10.1124/dmd.105.008250

  4. Chang, Chul-Hee

    1. STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
      Hwa-Kyung Lee, Joon-Kwan Moon, Chul-Hee Chang, Hoon Choi, Hee-Won Park, Byeoung-Soo Park, Hye-Suk Lee, Eul-Chul Hwang, Young-Deuk Lee, Kwang-Hyeon Liu and Jeong-Han Kim
      Drug Metabolism and Disposition July 2006, 34 (7) 1090-1095; DOI: https://doi.org/10.1124/dmd.105.009134

  5. Cheng, Olivia

    1. PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS
      Kevin J. Coe, Sidney D. Nelson, Roger G. Ulrich, Yudong He, Xudong Dai, Olivia Cheng, Michelle Caguyong, Chris J. Roberts and J. Greg Slatter
      Drug Metabolism and Disposition July 2006, 34 (7) 1266-1275; DOI: https://doi.org/10.1124/dmd.105.009159

  6. Cherrington, N. J.

    1. INDUCTION OF GENES FOR METABOLISM AND TRANSPORT BY TRANS-STILBENE OXIDE IN LIVERS OF SPRAGUE-DAWLEY AND WISTAR-KYOTO RATS
      A. L. Slitt, N. J. Cherrington, C. D. Fisher, M. Negishi and C. D. Klaassen
      Drug Metabolism and Disposition July 2006, 34 (7) 1190-1197; DOI: https://doi.org/10.1124/dmd.105.007542

  7. Chien, Jenny Y.

    1. STOCHASTIC PREDICTION OF CYP3A-MEDIATED INHIBITION OF MIDAZOLAM CLEARANCE BY KETOCONAZOLE
      Jenny Y. Chien, Aroonrut Lucksiri, Charles S. Ernest, J. Christopher Gorski, Steven A. Wrighton and Stephen D. Hall
      Drug Metabolism and Disposition July 2006, 34 (7) 1208-1219; DOI: https://doi.org/10.1124/dmd.105.008730

  8. Choi, Hoon

    1. STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
      Hwa-Kyung Lee, Joon-Kwan Moon, Chul-Hee Chang, Hoon Choi, Hee-Won Park, Byeoung-Soo Park, Hye-Suk Lee, Eul-Chul Hwang, Young-Deuk Lee, Kwang-Hyeon Liu and Jeong-Han Kim
      Drug Metabolism and Disposition July 2006, 34 (7) 1090-1095; DOI: https://doi.org/10.1124/dmd.105.009134

  9. Coe, Kevin J.

    1. PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS
      Kevin J. Coe, Sidney D. Nelson, Roger G. Ulrich, Yudong He, Xudong Dai, Olivia Cheng, Michelle Caguyong, Chris J. Roberts and J. Greg Slatter
      Drug Metabolism and Disposition July 2006, 34 (7) 1266-1275; DOI: https://doi.org/10.1124/dmd.105.009159

  10. Coombes, Catherine

    1. THE IN VIVO AND IN VITRO METABOLIC PROFILE OF 99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE
      David Edwards, Mark Battle, Rochelle Lear, Gill Farrar, D. Jon Barnett, Vanessa Godden, Catherine Coombes, Alexandra Oliveira and Håkan Ahlström
      Drug Metabolism and Disposition July 2006, 34 (7) 1128-1135; DOI: https://doi.org/10.1124/dmd.106.009696

  11. Court, Michael H.

    1. FACTORS INFLUENCING MIDAZOLAM HYDROXYLATION ACTIVITY IN HUMAN LIVER MICROSOMES
      Ping He, Michael H. Court, David J. Greenblatt and Lisa L. von Moltke
      Drug Metabolism and Disposition July 2006, 34 (7) 1198-1207; DOI: https://doi.org/10.1124/dmd.105.008904
    2. THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER
      Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
      Drug Metabolism and Disposition July 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787

D

  1. Dai, Xudong

    1. PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS
      Kevin J. Coe, Sidney D. Nelson, Roger G. Ulrich, Yudong He, Xudong Dai, Olivia Cheng, Michelle Caguyong, Chris J. Roberts and J. Greg Slatter
      Drug Metabolism and Disposition July 2006, 34 (7) 1266-1275; DOI: https://doi.org/10.1124/dmd.105.009159

  2. DeVane, C. Lindsay

    1. THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE
      Hao-Jie Zhu, Jun-Sheng Wang, C. Lindsay DeVane, Robin L. Williard, Jennifer L. Donovan, Lawrence D. Middaugh, Brian B. Gibson, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition July 2006, 34 (7) 1116-1121; DOI: https://doi.org/10.1124/dmd.106.009605

  3. Dong, Huan

    1. QUANTITATIVE DETERMINATION OF ARISTOLOCHIC ACID-DERIVED DNA ADDUCTS IN RATS USING 32P-POSTLABELING/POLYACRYLAMIDE GEL ELECTROPHORESIS ANALYSIS
      Huan Dong, Naomi Suzuki, Maria C. Torres, Radha R. Bonala, Francis Johnson, Arthur P. Grollman and Shinya Shibutani
      Drug Metabolism and Disposition July 2006, 34 (7) 1122-1127; DOI: https://doi.org/10.1124/dmd.105.008706

  4. Donovan, Jennifer L.

    1. THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE
      Hao-Jie Zhu, Jun-Sheng Wang, C. Lindsay DeVane, Robin L. Williard, Jennifer L. Donovan, Lawrence D. Middaugh, Brian B. Gibson, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition July 2006, 34 (7) 1116-1121; DOI: https://doi.org/10.1124/dmd.106.009605

E

  1. Ebner, Thomas

    1. PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS
      Naoki Ishiguro, Kazuya Maeda, Wataru Kishimoto, Asami Saito, Akiko Harada, Thomas Ebner, Willy Roth, Takashi Igarashi and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1109-1115; DOI: https://doi.org/10.1124/dmd.105.009175

  2. Eckloff, Bruce W.

    1. GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS
      Baidehi Mukherjee, Oreste E. Salavaggione, Linda L. Pelleymounter, Irene Moon, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben and Richard M. Weinshilboum
      Drug Metabolism and Disposition July 2006, 34 (7) 1237-1246; DOI: https://doi.org/10.1124/dmd.106.009613

  3. Edwards, David

    1. THE IN VIVO AND IN VITRO METABOLIC PROFILE OF 99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE
      David Edwards, Mark Battle, Rochelle Lear, Gill Farrar, D. Jon Barnett, Vanessa Godden, Catherine Coombes, Alexandra Oliveira and Håkan Ahlström
      Drug Metabolism and Disposition July 2006, 34 (7) 1128-1135; DOI: https://doi.org/10.1124/dmd.106.009696

  4. Ernest, Charles S.

    1. STOCHASTIC PREDICTION OF CYP3A-MEDIATED INHIBITION OF MIDAZOLAM CLEARANCE BY KETOCONAZOLE
      Jenny Y. Chien, Aroonrut Lucksiri, Charles S. Ernest, J. Christopher Gorski, Steven A. Wrighton and Stephen D. Hall
      Drug Metabolism and Disposition July 2006, 34 (7) 1208-1219; DOI: https://doi.org/10.1124/dmd.105.008730

  5. Evans, Christopher A.

    1. EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF “DISCOVERY-LIKE” MOLECULES TO PREDICT HUMAN PHARMACOKINETICS
      Christopher A. Evans, Larry J. Jolivette, Rakesh Nagilla and Keith W. Ward
      Drug Metabolism and Disposition July 2006, 34 (7) 1255-1265; DOI: https://doi.org/10.1124/dmd.105.006619

F

  1. Farrar, Gill

    1. THE IN VIVO AND IN VITRO METABOLIC PROFILE OF 99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE
      David Edwards, Mark Battle, Rochelle Lear, Gill Farrar, D. Jon Barnett, Vanessa Godden, Catherine Coombes, Alexandra Oliveira and Håkan Ahlström
      Drug Metabolism and Disposition July 2006, 34 (7) 1128-1135; DOI: https://doi.org/10.1124/dmd.106.009696

  2. Fisher, C. D.

    1. INDUCTION OF GENES FOR METABOLISM AND TRANSPORT BY TRANS-STILBENE OXIDE IN LIVERS OF SPRAGUE-DAWLEY AND WISTAR-KYOTO RATS
      A. L. Slitt, N. J. Cherrington, C. D. Fisher, M. Negishi and C. D. Klaassen
      Drug Metabolism and Disposition July 2006, 34 (7) 1190-1197; DOI: https://doi.org/10.1124/dmd.105.007542

  3. Forsell, Patrik

    1. FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL
      Niclas Petri, Ebba Bergman, Patrik Forsell, Mikael Hedeland, Ulf Bondesson, Lars Knutson and Hans Lennernäs
      Drug Metabolism and Disposition July 2006, 34 (7) 1182-1189; DOI: https://doi.org/10.1124/dmd.105.008409

  4. Fortier, Louis-Charles

    1. THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER
      Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
      Drug Metabolism and Disposition July 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787

G

  1. Gibson, Brian B.

    1. THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE
      Hao-Jie Zhu, Jun-Sheng Wang, C. Lindsay DeVane, Robin L. Williard, Jennifer L. Donovan, Lawrence D. Middaugh, Brian B. Gibson, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition July 2006, 34 (7) 1116-1121; DOI: https://doi.org/10.1124/dmd.106.009605

  2. Girard, Hugo

    1. THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER
      Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
      Drug Metabolism and Disposition July 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787

  3. Godden, Vanessa

    1. THE IN VIVO AND IN VITRO METABOLIC PROFILE OF 99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE
      David Edwards, Mark Battle, Rochelle Lear, Gill Farrar, D. Jon Barnett, Vanessa Godden, Catherine Coombes, Alexandra Oliveira and Håkan Ahlström
      Drug Metabolism and Disposition July 2006, 34 (7) 1128-1135; DOI: https://doi.org/10.1124/dmd.106.009696

  4. Gorski, J. Christopher

    1. STOCHASTIC PREDICTION OF CYP3A-MEDIATED INHIBITION OF MIDAZOLAM CLEARANCE BY KETOCONAZOLE
      Jenny Y. Chien, Aroonrut Lucksiri, Charles S. Ernest, J. Christopher Gorski, Steven A. Wrighton and Stephen D. Hall
      Drug Metabolism and Disposition July 2006, 34 (7) 1208-1219; DOI: https://doi.org/10.1124/dmd.105.008730

  5. Greenblatt, David J.

    1. FACTORS INFLUENCING MIDAZOLAM HYDROXYLATION ACTIVITY IN HUMAN LIVER MICROSOMES
      Ping He, Michael H. Court, David J. Greenblatt and Lisa L. von Moltke
      Drug Metabolism and Disposition July 2006, 34 (7) 1198-1207; DOI: https://doi.org/10.1124/dmd.105.008904
    2. THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER
      Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
      Drug Metabolism and Disposition July 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787

  6. Grollman, Arthur P.

    1. QUANTITATIVE DETERMINATION OF ARISTOLOCHIC ACID-DERIVED DNA ADDUCTS IN RATS USING 32P-POSTLABELING/POLYACRYLAMIDE GEL ELECTROPHORESIS ANALYSIS
      Huan Dong, Naomi Suzuki, Maria C. Torres, Radha R. Bonala, Francis Johnson, Arthur P. Grollman and Shinya Shibutani
      Drug Metabolism and Disposition July 2006, 34 (7) 1122-1127; DOI: https://doi.org/10.1124/dmd.105.008706

  7. Guglielmo, B. Joseph

    1. QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN
      Yong Huang, Hideaki Okochi, Barnaby C. H. May, Giuseppe Legname, Stanley B. Prusiner, Leslie Z. Benet, B. Joseph Guglielmo and Emil T. Lin
      Drug Metabolism and Disposition July 2006, 34 (7) 1136-1144; DOI: https://doi.org/10.1124/dmd.105.008664

  8. Guillemette, Chantal

    1. THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER
      Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
      Drug Metabolism and Disposition July 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787

  9. Guo, Jian

    1. IDENTIFICATION OF HUMAN HEPATIC CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 8-PRENYLNARINGENIN AND ISOXANTHOHUMOL FROM HOPS (HUMULUS LUPULUS L.)
      Jian Guo, Dejan Nikolic, Lucas R. Chadwick, Guido F. Pauli and Richard B. van Breemen
      Drug Metabolism and Disposition July 2006, 34 (7) 1152-1159; DOI: https://doi.org/10.1124/dmd.105.008250

H

  1. Haining, Robert L.

    1. EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF MOUSE CYP2D22
      Ai-Ming Yu and Robert L. Haining
      Drug Metabolism and Disposition July 2006, 34 (7) 1167-1174; DOI: https://doi.org/10.1124/dmd.105.008870

  2. Hall, Stephen D.

    1. STOCHASTIC PREDICTION OF CYP3A-MEDIATED INHIBITION OF MIDAZOLAM CLEARANCE BY KETOCONAZOLE
      Jenny Y. Chien, Aroonrut Lucksiri, Charles S. Ernest, J. Christopher Gorski, Steven A. Wrighton and Stephen D. Hall
      Drug Metabolism and Disposition July 2006, 34 (7) 1208-1219; DOI: https://doi.org/10.1124/dmd.105.008730

  3. Hao, Qin

    1. THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER
      Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
      Drug Metabolism and Disposition July 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787

  4. Harada, Akiko

    1. PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS
      Naoki Ishiguro, Kazuya Maeda, Wataru Kishimoto, Asami Saito, Akiko Harada, Thomas Ebner, Willy Roth, Takashi Igarashi and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1109-1115; DOI: https://doi.org/10.1124/dmd.105.009175

  5. He, Ping

    1. FACTORS INFLUENCING MIDAZOLAM HYDROXYLATION ACTIVITY IN HUMAN LIVER MICROSOMES
      Ping He, Michael H. Court, David J. Greenblatt and Lisa L. von Moltke
      Drug Metabolism and Disposition July 2006, 34 (7) 1198-1207; DOI: https://doi.org/10.1124/dmd.105.008904

  6. He, Yudong

    1. PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS
      Kevin J. Coe, Sidney D. Nelson, Roger G. Ulrich, Yudong He, Xudong Dai, Olivia Cheng, Michelle Caguyong, Chris J. Roberts and J. Greg Slatter
      Drug Metabolism and Disposition July 2006, 34 (7) 1266-1275; DOI: https://doi.org/10.1124/dmd.105.009159

  7. Hedeland, Mikael

    1. FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL
      Niclas Petri, Ebba Bergman, Patrik Forsell, Mikael Hedeland, Ulf Bondesson, Lars Knutson and Hans Lennernäs
      Drug Metabolism and Disposition July 2006, 34 (7) 1182-1189; DOI: https://doi.org/10.1124/dmd.105.008409

  8. Hirano, Masaru

    1. DRUG-DRUG INTERACTION BETWEEN PITAVASTATIN AND VARIOUS DRUGS VIA OATP1B1
      Masaru Hirano, Kazuya Maeda, Yoshihisa Shitara and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1229-1236; DOI: https://doi.org/10.1124/dmd.106.009290

  9. Hirouchi, Masakazu

    1. INVOLVEMENT OF TRANSPORTERS IN THE HEPATIC UPTAKE AND BILIARY EXCRETION OF VALSARTAN, A SELECTIVE ANTAGONIST OF THE ANGIOTENSIN II AT1-RECEPTOR, IN HUMANS
      Wakaba Yamashiro, Kazuya Maeda, Masakazu Hirouchi, Yasuhisa Adachi, Zhuohan Hu and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1247-1254; DOI: https://doi.org/10.1124/dmd.105.008938

  10. Hu, Zhuohan

    1. INVOLVEMENT OF TRANSPORTERS IN THE HEPATIC UPTAKE AND BILIARY EXCRETION OF VALSARTAN, A SELECTIVE ANTAGONIST OF THE ANGIOTENSIN II AT1-RECEPTOR, IN HUMANS
      Wakaba Yamashiro, Kazuya Maeda, Masakazu Hirouchi, Yasuhisa Adachi, Zhuohan Hu and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1247-1254; DOI: https://doi.org/10.1124/dmd.105.008938

  11. Huang, Yong

    1. QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN
      Yong Huang, Hideaki Okochi, Barnaby C. H. May, Giuseppe Legname, Stanley B. Prusiner, Leslie Z. Benet, B. Joseph Guglielmo and Emil T. Lin
      Drug Metabolism and Disposition July 2006, 34 (7) 1136-1144; DOI: https://doi.org/10.1124/dmd.105.008664
    2. PHARMACOKINETICS OF ATORVASTATIN AND ITS HYDROXY METABOLITES IN RATS AND THE EFFECTS OF CONCOMITANT RIFAMPICIN SINGLE DOSES: RELEVANCE OF FIRST-PASS EFFECT FROM HEPATIC UPTAKE TRANSPORTERS, AND INTESTINAL AND HEPATIC METABOLISM
      Yvonne Y. Lau, Hideaki Okochi, Yong Huang and Leslie Z. Benet
      Drug Metabolism and Disposition July 2006, 34 (7) 1175-1181; DOI: https://doi.org/10.1124/dmd.105.009076

  12. Hwang, Eul-Chul

    1. STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
      Hwa-Kyung Lee, Joon-Kwan Moon, Chul-Hee Chang, Hoon Choi, Hee-Won Park, Byeoung-Soo Park, Hye-Suk Lee, Eul-Chul Hwang, Young-Deuk Lee, Kwang-Hyeon Liu and Jeong-Han Kim
      Drug Metabolism and Disposition July 2006, 34 (7) 1090-1095; DOI: https://doi.org/10.1124/dmd.105.009134

I

  1. Igarashi, Takashi

    1. PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS
      Naoki Ishiguro, Kazuya Maeda, Wataru Kishimoto, Asami Saito, Akiko Harada, Thomas Ebner, Willy Roth, Takashi Igarashi and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1109-1115; DOI: https://doi.org/10.1124/dmd.105.009175

  2. Ikeda, Toshihiko

    1. HUMAN UDP-GLUCURONOSYLTRANSFERASE, UGT1A8, GLUCURONIDATES DIHYDROTESTOSTERONE TO A MONOGLUCURONIDE AND FURTHER TO A STRUCTURALLY NOVEL DIGLUCURONIDE
      Takahiro Murai, Naozumi Samata, Haruo Iwabuchi and Toshihiko Ikeda
      Drug Metabolism and Disposition July 2006, 34 (7) 1102-1108; DOI: https://doi.org/10.1124/dmd.106.009621

  3. Ishiguro, Naoki

    1. PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS
      Naoki Ishiguro, Kazuya Maeda, Wataru Kishimoto, Asami Saito, Akiko Harada, Thomas Ebner, Willy Roth, Takashi Igarashi and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1109-1115; DOI: https://doi.org/10.1124/dmd.105.009175

  4. Iwabuchi, Haruo

    1. HUMAN UDP-GLUCURONOSYLTRANSFERASE, UGT1A8, GLUCURONIDATES DIHYDROTESTOSTERONE TO A MONOGLUCURONIDE AND FURTHER TO A STRUCTURALLY NOVEL DIGLUCURONIDE
      Takahiro Murai, Naozumi Samata, Haruo Iwabuchi and Toshihiko Ikeda
      Drug Metabolism and Disposition July 2006, 34 (7) 1102-1108; DOI: https://doi.org/10.1124/dmd.106.009621

J

  1. Johnson, Francis

    1. QUANTITATIVE DETERMINATION OF ARISTOLOCHIC ACID-DERIVED DNA ADDUCTS IN RATS USING 32P-POSTLABELING/POLYACRYLAMIDE GEL ELECTROPHORESIS ANALYSIS
      Huan Dong, Naomi Suzuki, Maria C. Torres, Radha R. Bonala, Francis Johnson, Arthur P. Grollman and Shinya Shibutani
      Drug Metabolism and Disposition July 2006, 34 (7) 1122-1127; DOI: https://doi.org/10.1124/dmd.105.008706

  2. Jolivette, Larry J.

    1. EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF “DISCOVERY-LIKE” MOLECULES TO PREDICT HUMAN PHARMACOKINETICS
      Christopher A. Evans, Larry J. Jolivette, Rakesh Nagilla and Keith W. Ward
      Drug Metabolism and Disposition July 2006, 34 (7) 1255-1265; DOI: https://doi.org/10.1124/dmd.105.006619

K

  1. Kang, Ho-Jin

    1. NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS
      Ho-Jin Kang, Sang-Seop Lee, Chung-Hee Lee, Ju-Cheol Shim, Ho Jung Shin, Kwang-Hyeon Liu, Mi-Ae Yoo and Jae-Gook Shin
      Drug Metabolism and Disposition July 2006, 34 (7) 1145-1151; DOI: https://doi.org/10.1124/dmd.105.009126

  2. Kim, Jeong-Han

    1. STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
      Hwa-Kyung Lee, Joon-Kwan Moon, Chul-Hee Chang, Hoon Choi, Hee-Won Park, Byeoung-Soo Park, Hye-Suk Lee, Eul-Chul Hwang, Young-Deuk Lee, Kwang-Hyeon Liu and Jeong-Han Kim
      Drug Metabolism and Disposition July 2006, 34 (7) 1090-1095; DOI: https://doi.org/10.1124/dmd.105.009134

  3. Kishimoto, Wataru

    1. PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS
      Naoki Ishiguro, Kazuya Maeda, Wataru Kishimoto, Asami Saito, Akiko Harada, Thomas Ebner, Willy Roth, Takashi Igarashi and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1109-1115; DOI: https://doi.org/10.1124/dmd.105.009175

  4. Klaassen, C. D.

    1. INDUCTION OF GENES FOR METABOLISM AND TRANSPORT BY TRANS-STILBENE OXIDE IN LIVERS OF SPRAGUE-DAWLEY AND WISTAR-KYOTO RATS
      A. L. Slitt, N. J. Cherrington, C. D. Fisher, M. Negishi and C. D. Klaassen
      Drug Metabolism and Disposition July 2006, 34 (7) 1190-1197; DOI: https://doi.org/10.1124/dmd.105.007542

  5. Knutson, Lars

    1. FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL
      Niclas Petri, Ebba Bergman, Patrik Forsell, Mikael Hedeland, Ulf Bondesson, Lars Knutson and Hans Lennernäs
      Drug Metabolism and Disposition July 2006, 34 (7) 1182-1189; DOI: https://doi.org/10.1124/dmd.105.008409

  6. Köhle, Christoph

    1. REGULATION OF CYP1A1 GENE EXPRESSION BY THE ANTIOXIDANT TERT-BUTYLHYDROQUINONE
      Thomas D. Schreiber, Christoph Köhle, Felicitas Buckler, Stefan Schmohl, Albert Braeuning, Alexander Schmiechen, Michael Schwarz and Peter A. Münzel
      Drug Metabolism and Disposition July 2006, 34 (7) 1096-1101; DOI: https://doi.org/10.1124/dmd.106.009662

L

  1. Lau, Yvonne Y.

    1. PHARMACOKINETICS OF ATORVASTATIN AND ITS HYDROXY METABOLITES IN RATS AND THE EFFECTS OF CONCOMITANT RIFAMPICIN SINGLE DOSES: RELEVANCE OF FIRST-PASS EFFECT FROM HEPATIC UPTAKE TRANSPORTERS, AND INTESTINAL AND HEPATIC METABOLISM
      Yvonne Y. Lau, Hideaki Okochi, Yong Huang and Leslie Z. Benet
      Drug Metabolism and Disposition July 2006, 34 (7) 1175-1181; DOI: https://doi.org/10.1124/dmd.105.009076

  2. Lear, Rochelle

    1. THE IN VIVO AND IN VITRO METABOLIC PROFILE OF 99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE
      David Edwards, Mark Battle, Rochelle Lear, Gill Farrar, D. Jon Barnett, Vanessa Godden, Catherine Coombes, Alexandra Oliveira and Håkan Ahlström
      Drug Metabolism and Disposition July 2006, 34 (7) 1128-1135; DOI: https://doi.org/10.1124/dmd.106.009696

  3. Lee, Chung-Hee

    1. NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS
      Ho-Jin Kang, Sang-Seop Lee, Chung-Hee Lee, Ju-Cheol Shim, Ho Jung Shin, Kwang-Hyeon Liu, Mi-Ae Yoo and Jae-Gook Shin
      Drug Metabolism and Disposition July 2006, 34 (7) 1145-1151; DOI: https://doi.org/10.1124/dmd.105.009126

  4. Lee, Hwa-Kyung

    1. STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
      Hwa-Kyung Lee, Joon-Kwan Moon, Chul-Hee Chang, Hoon Choi, Hee-Won Park, Byeoung-Soo Park, Hye-Suk Lee, Eul-Chul Hwang, Young-Deuk Lee, Kwang-Hyeon Liu and Jeong-Han Kim
      Drug Metabolism and Disposition July 2006, 34 (7) 1090-1095; DOI: https://doi.org/10.1124/dmd.105.009134

  5. Lee, Hye-Suk

    1. STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
      Hwa-Kyung Lee, Joon-Kwan Moon, Chul-Hee Chang, Hoon Choi, Hee-Won Park, Byeoung-Soo Park, Hye-Suk Lee, Eul-Chul Hwang, Young-Deuk Lee, Kwang-Hyeon Liu and Jeong-Han Kim
      Drug Metabolism and Disposition July 2006, 34 (7) 1090-1095; DOI: https://doi.org/10.1124/dmd.105.009134

  6. Lee, Sang-Seop

    1. NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS
      Ho-Jin Kang, Sang-Seop Lee, Chung-Hee Lee, Ju-Cheol Shim, Ho Jung Shin, Kwang-Hyeon Liu, Mi-Ae Yoo and Jae-Gook Shin
      Drug Metabolism and Disposition July 2006, 34 (7) 1145-1151; DOI: https://doi.org/10.1124/dmd.105.009126

  7. Lee, Young-Deuk

    1. STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
      Hwa-Kyung Lee, Joon-Kwan Moon, Chul-Hee Chang, Hoon Choi, Hee-Won Park, Byeoung-Soo Park, Hye-Suk Lee, Eul-Chul Hwang, Young-Deuk Lee, Kwang-Hyeon Liu and Jeong-Han Kim
      Drug Metabolism and Disposition July 2006, 34 (7) 1090-1095; DOI: https://doi.org/10.1124/dmd.105.009134

  8. Legname, Giuseppe

    1. QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN
      Yong Huang, Hideaki Okochi, Barnaby C. H. May, Giuseppe Legname, Stanley B. Prusiner, Leslie Z. Benet, B. Joseph Guglielmo and Emil T. Lin
      Drug Metabolism and Disposition July 2006, 34 (7) 1136-1144; DOI: https://doi.org/10.1124/dmd.105.008664

  9. Lennernäs, Hans

    1. FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL
      Niclas Petri, Ebba Bergman, Patrik Forsell, Mikael Hedeland, Ulf Bondesson, Lars Knutson and Hans Lennernäs
      Drug Metabolism and Disposition July 2006, 34 (7) 1182-1189; DOI: https://doi.org/10.1124/dmd.105.008409

  10. Lin, Emil T.

    1. QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN
      Yong Huang, Hideaki Okochi, Barnaby C. H. May, Giuseppe Legname, Stanley B. Prusiner, Leslie Z. Benet, B. Joseph Guglielmo and Emil T. Lin
      Drug Metabolism and Disposition July 2006, 34 (7) 1136-1144; DOI: https://doi.org/10.1124/dmd.105.008664

  11. Liu, Kwang-Hyeon

    1. STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
      Hwa-Kyung Lee, Joon-Kwan Moon, Chul-Hee Chang, Hoon Choi, Hee-Won Park, Byeoung-Soo Park, Hye-Suk Lee, Eul-Chul Hwang, Young-Deuk Lee, Kwang-Hyeon Liu and Jeong-Han Kim
      Drug Metabolism and Disposition July 2006, 34 (7) 1090-1095; DOI: https://doi.org/10.1124/dmd.105.009134
    2. NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS
      Ho-Jin Kang, Sang-Seop Lee, Chung-Hee Lee, Ju-Cheol Shim, Ho Jung Shin, Kwang-Hyeon Liu, Mi-Ae Yoo and Jae-Gook Shin
      Drug Metabolism and Disposition July 2006, 34 (7) 1145-1151; DOI: https://doi.org/10.1124/dmd.105.009126

  12. Lucksiri, Aroonrut

    1. STOCHASTIC PREDICTION OF CYP3A-MEDIATED INHIBITION OF MIDAZOLAM CLEARANCE BY KETOCONAZOLE
      Jenny Y. Chien, Aroonrut Lucksiri, Charles S. Ernest, J. Christopher Gorski, Steven A. Wrighton and Stephen D. Hall
      Drug Metabolism and Disposition July 2006, 34 (7) 1208-1219; DOI: https://doi.org/10.1124/dmd.105.008730

M

  1. Maeda, Kazuya

    1. PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS
      Naoki Ishiguro, Kazuya Maeda, Wataru Kishimoto, Asami Saito, Akiko Harada, Thomas Ebner, Willy Roth, Takashi Igarashi and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1109-1115; DOI: https://doi.org/10.1124/dmd.105.009175
    2. DRUG-DRUG INTERACTION BETWEEN PITAVASTATIN AND VARIOUS DRUGS VIA OATP1B1
      Masaru Hirano, Kazuya Maeda, Yoshihisa Shitara and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1229-1236; DOI: https://doi.org/10.1124/dmd.106.009290
    3. INVOLVEMENT OF TRANSPORTERS IN THE HEPATIC UPTAKE AND BILIARY EXCRETION OF VALSARTAN, A SELECTIVE ANTAGONIST OF THE ANGIOTENSIN II AT1-RECEPTOR, IN HUMANS
      Wakaba Yamashiro, Kazuya Maeda, Masakazu Hirouchi, Yasuhisa Adachi, Zhuohan Hu and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1247-1254; DOI: https://doi.org/10.1124/dmd.105.008938

  2. Markowitz, John S.

    1. THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE
      Hao-Jie Zhu, Jun-Sheng Wang, C. Lindsay DeVane, Robin L. Williard, Jennifer L. Donovan, Lawrence D. Middaugh, Brian B. Gibson, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition July 2006, 34 (7) 1116-1121; DOI: https://doi.org/10.1124/dmd.106.009605

  3. May, Barnaby C. H.

    1. QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN
      Yong Huang, Hideaki Okochi, Barnaby C. H. May, Giuseppe Legname, Stanley B. Prusiner, Leslie Z. Benet, B. Joseph Guglielmo and Emil T. Lin
      Drug Metabolism and Disposition July 2006, 34 (7) 1136-1144; DOI: https://doi.org/10.1124/dmd.105.008664

  4. Mehvar, Reza

    1. SELECTIVE EFFECTS OF NITRIC OXIDE ON THE DISPOSITION OF CHLORZOXAZONE AND DEXTROMETHORPHAN IN ISOLATED PERFUSED RAT LIVERS
      Ragini Vuppugalla and Reza Mehvar
      Drug Metabolism and Disposition July 2006, 34 (7) 1160-1166; DOI: https://doi.org/10.1124/dmd.105.009050

  5. Middaugh, Lawrence D.

    1. THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE
      Hao-Jie Zhu, Jun-Sheng Wang, C. Lindsay DeVane, Robin L. Williard, Jennifer L. Donovan, Lawrence D. Middaugh, Brian B. Gibson, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition July 2006, 34 (7) 1116-1121; DOI: https://doi.org/10.1124/dmd.106.009605

  6. Miwa, Masao

    1. INDUCTION OF DETOXIFYING ENZYMES IN RODENT WHITE ADIPOSE TISSUE BY ARYL HYDROCARBON RECEPTOR AGONISTS AND ANTIOXIDANTS
      Kouichi Yoshinari, Nao Okino, Takeshi Sato, Junko Sugatani and Masao Miwa
      Drug Metabolism and Disposition July 2006, 34 (7) 1081-1089; DOI: https://doi.org/10.1124/dmd.105.007286

  7. Moon, Irene

    1. GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS
      Baidehi Mukherjee, Oreste E. Salavaggione, Linda L. Pelleymounter, Irene Moon, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben and Richard M. Weinshilboum
      Drug Metabolism and Disposition July 2006, 34 (7) 1237-1246; DOI: https://doi.org/10.1124/dmd.106.009613

  8. Moon, Joon-Kwan

    1. STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
      Hwa-Kyung Lee, Joon-Kwan Moon, Chul-Hee Chang, Hoon Choi, Hee-Won Park, Byeoung-Soo Park, Hye-Suk Lee, Eul-Chul Hwang, Young-Deuk Lee, Kwang-Hyeon Liu and Jeong-Han Kim
      Drug Metabolism and Disposition July 2006, 34 (7) 1090-1095; DOI: https://doi.org/10.1124/dmd.105.009134

  9. Mukherjee, Baidehi

    1. GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS
      Baidehi Mukherjee, Oreste E. Salavaggione, Linda L. Pelleymounter, Irene Moon, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben and Richard M. Weinshilboum
      Drug Metabolism and Disposition July 2006, 34 (7) 1237-1246; DOI: https://doi.org/10.1124/dmd.106.009613

  10. Münzel, Peter A.

    1. REGULATION OF CYP1A1 GENE EXPRESSION BY THE ANTIOXIDANT TERT-BUTYLHYDROQUINONE
      Thomas D. Schreiber, Christoph Köhle, Felicitas Buckler, Stefan Schmohl, Albert Braeuning, Alexander Schmiechen, Michael Schwarz and Peter A. Münzel
      Drug Metabolism and Disposition July 2006, 34 (7) 1096-1101; DOI: https://doi.org/10.1124/dmd.106.009662

  11. Murai, Takahiro

    1. HUMAN UDP-GLUCURONOSYLTRANSFERASE, UGT1A8, GLUCURONIDATES DIHYDROTESTOSTERONE TO A MONOGLUCURONIDE AND FURTHER TO A STRUCTURALLY NOVEL DIGLUCURONIDE
      Takahiro Murai, Naozumi Samata, Haruo Iwabuchi and Toshihiko Ikeda
      Drug Metabolism and Disposition July 2006, 34 (7) 1102-1108; DOI: https://doi.org/10.1124/dmd.106.009621

N

  1. Nagilla, Rakesh

    1. EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF “DISCOVERY-LIKE” MOLECULES TO PREDICT HUMAN PHARMACOKINETICS
      Christopher A. Evans, Larry J. Jolivette, Rakesh Nagilla and Keith W. Ward
      Drug Metabolism and Disposition July 2006, 34 (7) 1255-1265; DOI: https://doi.org/10.1124/dmd.105.006619

  2. Negishi, M.

    1. INDUCTION OF GENES FOR METABOLISM AND TRANSPORT BY TRANS-STILBENE OXIDE IN LIVERS OF SPRAGUE-DAWLEY AND WISTAR-KYOTO RATS
      A. L. Slitt, N. J. Cherrington, C. D. Fisher, M. Negishi and C. D. Klaassen
      Drug Metabolism and Disposition July 2006, 34 (7) 1190-1197; DOI: https://doi.org/10.1124/dmd.105.007542

  3. Nelson, Sidney D.

    1. PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS
      Kevin J. Coe, Sidney D. Nelson, Roger G. Ulrich, Yudong He, Xudong Dai, Olivia Cheng, Michelle Caguyong, Chris J. Roberts and J. Greg Slatter
      Drug Metabolism and Disposition July 2006, 34 (7) 1266-1275; DOI: https://doi.org/10.1124/dmd.105.009159

  4. Nikolic, Dejan

    1. IDENTIFICATION OF HUMAN HEPATIC CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 8-PRENYLNARINGENIN AND ISOXANTHOHUMOL FROM HOPS (HUMULUS LUPULUS L.)
      Jian Guo, Dejan Nikolic, Lucas R. Chadwick, Guido F. Pauli and Richard B. van Breemen
      Drug Metabolism and Disposition July 2006, 34 (7) 1152-1159; DOI: https://doi.org/10.1124/dmd.105.008250

O

  1. Okino, Nao

    1. INDUCTION OF DETOXIFYING ENZYMES IN RODENT WHITE ADIPOSE TISSUE BY ARYL HYDROCARBON RECEPTOR AGONISTS AND ANTIOXIDANTS
      Kouichi Yoshinari, Nao Okino, Takeshi Sato, Junko Sugatani and Masao Miwa
      Drug Metabolism and Disposition July 2006, 34 (7) 1081-1089; DOI: https://doi.org/10.1124/dmd.105.007286

  2. Okochi, Hideaki

    1. QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN
      Yong Huang, Hideaki Okochi, Barnaby C. H. May, Giuseppe Legname, Stanley B. Prusiner, Leslie Z. Benet, B. Joseph Guglielmo and Emil T. Lin
      Drug Metabolism and Disposition July 2006, 34 (7) 1136-1144; DOI: https://doi.org/10.1124/dmd.105.008664
    2. PHARMACOKINETICS OF ATORVASTATIN AND ITS HYDROXY METABOLITES IN RATS AND THE EFFECTS OF CONCOMITANT RIFAMPICIN SINGLE DOSES: RELEVANCE OF FIRST-PASS EFFECT FROM HEPATIC UPTAKE TRANSPORTERS, AND INTESTINAL AND HEPATIC METABOLISM
      Yvonne Y. Lau, Hideaki Okochi, Yong Huang and Leslie Z. Benet
      Drug Metabolism and Disposition July 2006, 34 (7) 1175-1181; DOI: https://doi.org/10.1124/dmd.105.009076

  3. Oliveira, Alexandra

    1. THE IN VIVO AND IN VITRO METABOLIC PROFILE OF 99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE
      David Edwards, Mark Battle, Rochelle Lear, Gill Farrar, D. Jon Barnett, Vanessa Godden, Catherine Coombes, Alexandra Oliveira and Håkan Ahlström
      Drug Metabolism and Disposition July 2006, 34 (7) 1128-1135; DOI: https://doi.org/10.1124/dmd.106.009696

P

  1. Park, Byeoung-Soo

    1. STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
      Hwa-Kyung Lee, Joon-Kwan Moon, Chul-Hee Chang, Hoon Choi, Hee-Won Park, Byeoung-Soo Park, Hye-Suk Lee, Eul-Chul Hwang, Young-Deuk Lee, Kwang-Hyeon Liu and Jeong-Han Kim
      Drug Metabolism and Disposition July 2006, 34 (7) 1090-1095; DOI: https://doi.org/10.1124/dmd.105.009134

  2. Park, Hee-Won

    1. STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS
      Hwa-Kyung Lee, Joon-Kwan Moon, Chul-Hee Chang, Hoon Choi, Hee-Won Park, Byeoung-Soo Park, Hye-Suk Lee, Eul-Chul Hwang, Young-Deuk Lee, Kwang-Hyeon Liu and Jeong-Han Kim
      Drug Metabolism and Disposition July 2006, 34 (7) 1090-1095; DOI: https://doi.org/10.1124/dmd.105.009134

  3. Patrick, Kennerly S.

    1. THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE
      Hao-Jie Zhu, Jun-Sheng Wang, C. Lindsay DeVane, Robin L. Williard, Jennifer L. Donovan, Lawrence D. Middaugh, Brian B. Gibson, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition July 2006, 34 (7) 1116-1121; DOI: https://doi.org/10.1124/dmd.106.009605

  4. Pauli, Guido F.

    1. IDENTIFICATION OF HUMAN HEPATIC CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 8-PRENYLNARINGENIN AND ISOXANTHOHUMOL FROM HOPS (HUMULUS LUPULUS L.)
      Jian Guo, Dejan Nikolic, Lucas R. Chadwick, Guido F. Pauli and Richard B. van Breemen
      Drug Metabolism and Disposition July 2006, 34 (7) 1152-1159; DOI: https://doi.org/10.1124/dmd.105.008250

  5. Pelleymounter, Linda L.

    1. GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS
      Baidehi Mukherjee, Oreste E. Salavaggione, Linda L. Pelleymounter, Irene Moon, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben and Richard M. Weinshilboum
      Drug Metabolism and Disposition July 2006, 34 (7) 1237-1246; DOI: https://doi.org/10.1124/dmd.106.009613

  6. Petri, Niclas

    1. FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL
      Niclas Petri, Ebba Bergman, Patrik Forsell, Mikael Hedeland, Ulf Bondesson, Lars Knutson and Hans Lennernäs
      Drug Metabolism and Disposition July 2006, 34 (7) 1182-1189; DOI: https://doi.org/10.1124/dmd.105.008409

  7. Prusiner, Stanley B.

    1. QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN
      Yong Huang, Hideaki Okochi, Barnaby C. H. May, Giuseppe Legname, Stanley B. Prusiner, Leslie Z. Benet, B. Joseph Guglielmo and Emil T. Lin
      Drug Metabolism and Disposition July 2006, 34 (7) 1136-1144; DOI: https://doi.org/10.1124/dmd.105.008664

R

  1. Roberts, Chris J.

    1. PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS
      Kevin J. Coe, Sidney D. Nelson, Roger G. Ulrich, Yudong He, Xudong Dai, Olivia Cheng, Michelle Caguyong, Chris J. Roberts and J. Greg Slatter
      Drug Metabolism and Disposition July 2006, 34 (7) 1266-1275; DOI: https://doi.org/10.1124/dmd.105.009159

  2. Roth, Willy

    1. PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS
      Naoki Ishiguro, Kazuya Maeda, Wataru Kishimoto, Asami Saito, Akiko Harada, Thomas Ebner, Willy Roth, Takashi Igarashi and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1109-1115; DOI: https://doi.org/10.1124/dmd.105.009175

S

  1. Saito, Asami

    1. PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS
      Naoki Ishiguro, Kazuya Maeda, Wataru Kishimoto, Asami Saito, Akiko Harada, Thomas Ebner, Willy Roth, Takashi Igarashi and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1109-1115; DOI: https://doi.org/10.1124/dmd.105.009175

  2. Salavaggione, Oreste E.

    1. GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS
      Baidehi Mukherjee, Oreste E. Salavaggione, Linda L. Pelleymounter, Irene Moon, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben and Richard M. Weinshilboum
      Drug Metabolism and Disposition July 2006, 34 (7) 1237-1246; DOI: https://doi.org/10.1124/dmd.106.009613

  3. Samata, Naozumi

    1. HUMAN UDP-GLUCURONOSYLTRANSFERASE, UGT1A8, GLUCURONIDATES DIHYDROTESTOSTERONE TO A MONOGLUCURONIDE AND FURTHER TO A STRUCTURALLY NOVEL DIGLUCURONIDE
      Takahiro Murai, Naozumi Samata, Haruo Iwabuchi and Toshihiko Ikeda
      Drug Metabolism and Disposition July 2006, 34 (7) 1102-1108; DOI: https://doi.org/10.1124/dmd.106.009621

  4. Sato, Takeshi

    1. INDUCTION OF DETOXIFYING ENZYMES IN RODENT WHITE ADIPOSE TISSUE BY ARYL HYDROCARBON RECEPTOR AGONISTS AND ANTIOXIDANTS
      Kouichi Yoshinari, Nao Okino, Takeshi Sato, Junko Sugatani and Masao Miwa
      Drug Metabolism and Disposition July 2006, 34 (7) 1081-1089; DOI: https://doi.org/10.1124/dmd.105.007286

  5. Schaid, Daniel J.

    1. GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS
      Baidehi Mukherjee, Oreste E. Salavaggione, Linda L. Pelleymounter, Irene Moon, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben and Richard M. Weinshilboum
      Drug Metabolism and Disposition July 2006, 34 (7) 1237-1246; DOI: https://doi.org/10.1124/dmd.106.009613

  6. Schmiechen, Alexander

    1. REGULATION OF CYP1A1 GENE EXPRESSION BY THE ANTIOXIDANT TERT-BUTYLHYDROQUINONE
      Thomas D. Schreiber, Christoph Köhle, Felicitas Buckler, Stefan Schmohl, Albert Braeuning, Alexander Schmiechen, Michael Schwarz and Peter A. Münzel
      Drug Metabolism and Disposition July 2006, 34 (7) 1096-1101; DOI: https://doi.org/10.1124/dmd.106.009662

  7. Schmohl, Stefan

    1. REGULATION OF CYP1A1 GENE EXPRESSION BY THE ANTIOXIDANT TERT-BUTYLHYDROQUINONE
      Thomas D. Schreiber, Christoph Köhle, Felicitas Buckler, Stefan Schmohl, Albert Braeuning, Alexander Schmiechen, Michael Schwarz and Peter A. Münzel
      Drug Metabolism and Disposition July 2006, 34 (7) 1096-1101; DOI: https://doi.org/10.1124/dmd.106.009662

  8. Schreiber, Thomas D.

    1. REGULATION OF CYP1A1 GENE EXPRESSION BY THE ANTIOXIDANT TERT-BUTYLHYDROQUINONE
      Thomas D. Schreiber, Christoph Köhle, Felicitas Buckler, Stefan Schmohl, Albert Braeuning, Alexander Schmiechen, Michael Schwarz and Peter A. Münzel
      Drug Metabolism and Disposition July 2006, 34 (7) 1096-1101; DOI: https://doi.org/10.1124/dmd.106.009662

  9. Schwarz, Michael

    1. REGULATION OF CYP1A1 GENE EXPRESSION BY THE ANTIOXIDANT TERT-BUTYLHYDROQUINONE
      Thomas D. Schreiber, Christoph Köhle, Felicitas Buckler, Stefan Schmohl, Albert Braeuning, Alexander Schmiechen, Michael Schwarz and Peter A. Münzel
      Drug Metabolism and Disposition July 2006, 34 (7) 1096-1101; DOI: https://doi.org/10.1124/dmd.106.009662

  10. Shibutani, Shinya

    1. QUANTITATIVE DETERMINATION OF ARISTOLOCHIC ACID-DERIVED DNA ADDUCTS IN RATS USING 32P-POSTLABELING/POLYACRYLAMIDE GEL ELECTROPHORESIS ANALYSIS
      Huan Dong, Naomi Suzuki, Maria C. Torres, Radha R. Bonala, Francis Johnson, Arthur P. Grollman and Shinya Shibutani
      Drug Metabolism and Disposition July 2006, 34 (7) 1122-1127; DOI: https://doi.org/10.1124/dmd.105.008706

  11. Shim, Ju-Cheol

    1. NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS
      Ho-Jin Kang, Sang-Seop Lee, Chung-Hee Lee, Ju-Cheol Shim, Ho Jung Shin, Kwang-Hyeon Liu, Mi-Ae Yoo and Jae-Gook Shin
      Drug Metabolism and Disposition July 2006, 34 (7) 1145-1151; DOI: https://doi.org/10.1124/dmd.105.009126

  12. Shin, Ho Jung

    1. NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS
      Ho-Jin Kang, Sang-Seop Lee, Chung-Hee Lee, Ju-Cheol Shim, Ho Jung Shin, Kwang-Hyeon Liu, Mi-Ae Yoo and Jae-Gook Shin
      Drug Metabolism and Disposition July 2006, 34 (7) 1145-1151; DOI: https://doi.org/10.1124/dmd.105.009126

  13. Shin, Jae-Gook

    1. NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS
      Ho-Jin Kang, Sang-Seop Lee, Chung-Hee Lee, Ju-Cheol Shim, Ho Jung Shin, Kwang-Hyeon Liu, Mi-Ae Yoo and Jae-Gook Shin
      Drug Metabolism and Disposition July 2006, 34 (7) 1145-1151; DOI: https://doi.org/10.1124/dmd.105.009126

  14. Shitara, Yoshihisa

    1. DRUG-DRUG INTERACTION BETWEEN PITAVASTATIN AND VARIOUS DRUGS VIA OATP1B1
      Masaru Hirano, Kazuya Maeda, Yoshihisa Shitara and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1229-1236; DOI: https://doi.org/10.1124/dmd.106.009290

  15. Slatter, J. Greg

    1. PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS
      Kevin J. Coe, Sidney D. Nelson, Roger G. Ulrich, Yudong He, Xudong Dai, Olivia Cheng, Michelle Caguyong, Chris J. Roberts and J. Greg Slatter
      Drug Metabolism and Disposition July 2006, 34 (7) 1266-1275; DOI: https://doi.org/10.1124/dmd.105.009159

  16. Slitt, A. L.

    1. INDUCTION OF GENES FOR METABOLISM AND TRANSPORT BY TRANS-STILBENE OXIDE IN LIVERS OF SPRAGUE-DAWLEY AND WISTAR-KYOTO RATS
      A. L. Slitt, N. J. Cherrington, C. D. Fisher, M. Negishi and C. D. Klaassen
      Drug Metabolism and Disposition July 2006, 34 (7) 1190-1197; DOI: https://doi.org/10.1124/dmd.105.007542

  17. Sugatani, Junko

    1. INDUCTION OF DETOXIFYING ENZYMES IN RODENT WHITE ADIPOSE TISSUE BY ARYL HYDROCARBON RECEPTOR AGONISTS AND ANTIOXIDANTS
      Kouichi Yoshinari, Nao Okino, Takeshi Sato, Junko Sugatani and Masao Miwa
      Drug Metabolism and Disposition July 2006, 34 (7) 1081-1089; DOI: https://doi.org/10.1124/dmd.105.007286

  18. Sugiyama, Yuichi

    1. PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS
      Naoki Ishiguro, Kazuya Maeda, Wataru Kishimoto, Asami Saito, Akiko Harada, Thomas Ebner, Willy Roth, Takashi Igarashi and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1109-1115; DOI: https://doi.org/10.1124/dmd.105.009175
    2. DRUG-DRUG INTERACTION BETWEEN PITAVASTATIN AND VARIOUS DRUGS VIA OATP1B1
      Masaru Hirano, Kazuya Maeda, Yoshihisa Shitara and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1229-1236; DOI: https://doi.org/10.1124/dmd.106.009290
    3. INVOLVEMENT OF TRANSPORTERS IN THE HEPATIC UPTAKE AND BILIARY EXCRETION OF VALSARTAN, A SELECTIVE ANTAGONIST OF THE ANGIOTENSIN II AT1-RECEPTOR, IN HUMANS
      Wakaba Yamashiro, Kazuya Maeda, Masakazu Hirouchi, Yasuhisa Adachi, Zhuohan Hu and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1247-1254; DOI: https://doi.org/10.1124/dmd.105.008938

  19. Suzuki, Naomi

    1. QUANTITATIVE DETERMINATION OF ARISTOLOCHIC ACID-DERIVED DNA ADDUCTS IN RATS USING 32P-POSTLABELING/POLYACRYLAMIDE GEL ELECTROPHORESIS ANALYSIS
      Huan Dong, Naomi Suzuki, Maria C. Torres, Radha R. Bonala, Francis Johnson, Arthur P. Grollman and Shinya Shibutani
      Drug Metabolism and Disposition July 2006, 34 (7) 1122-1127; DOI: https://doi.org/10.1124/dmd.105.008706

T

  1. Torres, Maria C.

    1. QUANTITATIVE DETERMINATION OF ARISTOLOCHIC ACID-DERIVED DNA ADDUCTS IN RATS USING 32P-POSTLABELING/POLYACRYLAMIDE GEL ELECTROPHORESIS ANALYSIS
      Huan Dong, Naomi Suzuki, Maria C. Torres, Radha R. Bonala, Francis Johnson, Arthur P. Grollman and Shinya Shibutani
      Drug Metabolism and Disposition July 2006, 34 (7) 1122-1127; DOI: https://doi.org/10.1124/dmd.105.008706

U

  1. Ulrich, Roger G.

    1. PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS
      Kevin J. Coe, Sidney D. Nelson, Roger G. Ulrich, Yudong He, Xudong Dai, Olivia Cheng, Michelle Caguyong, Chris J. Roberts and J. Greg Slatter
      Drug Metabolism and Disposition July 2006, 34 (7) 1266-1275; DOI: https://doi.org/10.1124/dmd.105.009159

V

  1. van Breemen, Richard B.

    1. IDENTIFICATION OF HUMAN HEPATIC CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 8-PRENYLNARINGENIN AND ISOXANTHOHUMOL FROM HOPS (HUMULUS LUPULUS L.)
      Jian Guo, Dejan Nikolic, Lucas R. Chadwick, Guido F. Pauli and Richard B. van Breemen
      Drug Metabolism and Disposition July 2006, 34 (7) 1152-1159; DOI: https://doi.org/10.1124/dmd.105.008250

  2. Villeneuve, Lyne

    1. THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER
      Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
      Drug Metabolism and Disposition July 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787

  3. von Moltke, Lisa L.

    1. FACTORS INFLUENCING MIDAZOLAM HYDROXYLATION ACTIVITY IN HUMAN LIVER MICROSOMES
      Ping He, Michael H. Court, David J. Greenblatt and Lisa L. von Moltke
      Drug Metabolism and Disposition July 2006, 34 (7) 1198-1207; DOI: https://doi.org/10.1124/dmd.105.008904
    2. THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER
      Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
      Drug Metabolism and Disposition July 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787

  4. Vuppugalla, Ragini

    1. SELECTIVE EFFECTS OF NITRIC OXIDE ON THE DISPOSITION OF CHLORZOXAZONE AND DEXTROMETHORPHAN IN ISOLATED PERFUSED RAT LIVERS
      Ragini Vuppugalla and Reza Mehvar
      Drug Metabolism and Disposition July 2006, 34 (7) 1160-1166; DOI: https://doi.org/10.1124/dmd.105.009050

W

  1. Wang, Jun-Sheng

    1. THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE
      Hao-Jie Zhu, Jun-Sheng Wang, C. Lindsay DeVane, Robin L. Williard, Jennifer L. Donovan, Lawrence D. Middaugh, Brian B. Gibson, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition July 2006, 34 (7) 1116-1121; DOI: https://doi.org/10.1124/dmd.106.009605

  2. Ward, Keith W.

    1. EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF “DISCOVERY-LIKE” MOLECULES TO PREDICT HUMAN PHARMACOKINETICS
      Christopher A. Evans, Larry J. Jolivette, Rakesh Nagilla and Keith W. Ward
      Drug Metabolism and Disposition July 2006, 34 (7) 1255-1265; DOI: https://doi.org/10.1124/dmd.105.006619

  3. Weinshilboum, Richard M.

    1. GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS
      Baidehi Mukherjee, Oreste E. Salavaggione, Linda L. Pelleymounter, Irene Moon, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben and Richard M. Weinshilboum
      Drug Metabolism and Disposition July 2006, 34 (7) 1237-1246; DOI: https://doi.org/10.1124/dmd.106.009613

  4. Wieben, Eric D.

    1. GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS
      Baidehi Mukherjee, Oreste E. Salavaggione, Linda L. Pelleymounter, Irene Moon, Bruce W. Eckloff, Daniel J. Schaid, Eric D. Wieben and Richard M. Weinshilboum
      Drug Metabolism and Disposition July 2006, 34 (7) 1237-1246; DOI: https://doi.org/10.1124/dmd.106.009613

  5. Williard, Robin L.

    1. THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE
      Hao-Jie Zhu, Jun-Sheng Wang, C. Lindsay DeVane, Robin L. Williard, Jennifer L. Donovan, Lawrence D. Middaugh, Brian B. Gibson, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition July 2006, 34 (7) 1116-1121; DOI: https://doi.org/10.1124/dmd.106.009605

  6. Wrighton, Steven A.

    1. STOCHASTIC PREDICTION OF CYP3A-MEDIATED INHIBITION OF MIDAZOLAM CLEARANCE BY KETOCONAZOLE
      Jenny Y. Chien, Aroonrut Lucksiri, Charles S. Ernest, J. Christopher Gorski, Steven A. Wrighton and Stephen D. Hall
      Drug Metabolism and Disposition July 2006, 34 (7) 1208-1219; DOI: https://doi.org/10.1124/dmd.105.008730

Y

  1. Yamashiro, Wakaba

    1. INVOLVEMENT OF TRANSPORTERS IN THE HEPATIC UPTAKE AND BILIARY EXCRETION OF VALSARTAN, A SELECTIVE ANTAGONIST OF THE ANGIOTENSIN II AT1-RECEPTOR, IN HUMANS
      Wakaba Yamashiro, Kazuya Maeda, Masakazu Hirouchi, Yasuhisa Adachi, Zhuohan Hu and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2006, 34 (7) 1247-1254; DOI: https://doi.org/10.1124/dmd.105.008938

  2. Yoo, Mi-Ae

    1. NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS
      Ho-Jin Kang, Sang-Seop Lee, Chung-Hee Lee, Ju-Cheol Shim, Ho Jung Shin, Kwang-Hyeon Liu, Mi-Ae Yoo and Jae-Gook Shin
      Drug Metabolism and Disposition July 2006, 34 (7) 1145-1151; DOI: https://doi.org/10.1124/dmd.105.009126

  3. Yoshinari, Kouichi

    1. INDUCTION OF DETOXIFYING ENZYMES IN RODENT WHITE ADIPOSE TISSUE BY ARYL HYDROCARBON RECEPTOR AGONISTS AND ANTIOXIDANTS
      Kouichi Yoshinari, Nao Okino, Takeshi Sato, Junko Sugatani and Masao Miwa
      Drug Metabolism and Disposition July 2006, 34 (7) 1081-1089; DOI: https://doi.org/10.1124/dmd.105.007286

  4. Yu, Ai-Ming

    1. EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF MOUSE CYP2D22
      Ai-Ming Yu and Robert L. Haining
      Drug Metabolism and Disposition July 2006, 34 (7) 1167-1174; DOI: https://doi.org/10.1124/dmd.105.008870

Z

  1. Zhu, Hao-Jie

    1. THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE
      Hao-Jie Zhu, Jun-Sheng Wang, C. Lindsay DeVane, Robin L. Williard, Jennifer L. Donovan, Lawrence D. Middaugh, Brian B. Gibson, Kennerly S. Patrick and John S. Markowitz
      Drug Metabolism and Disposition July 2006, 34 (7) 1116-1121; DOI: https://doi.org/10.1124/dmd.106.009605
Back to top

In this issue